Nutra Pharma Corp. (NPHC)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Aug 17, 2026, 4:00 PM EST
Nutra Pharma Revenue
Nutra Pharma had revenue of $48.21K in the quarter ending March 31, 2026, a decrease of -56.33%. This brings the company's revenue in the last twelve months to $323.13K, down -24.83% year-over-year. In the year 2025, Nutra Pharma had annual revenue of $385.31K, down -1.74%.
Revenue (ttm)
323.13K
Revenue Growth
-24.83%
P/S Ratio
2.22
Revenue / Employee
53.85K
Employees
6
Market Cap
715.97K
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 385.31K | -6.84K | -1.74% |
| Dec 31, 2024 | 392.15K | -202.73K | -34.08% |
| Dec 31, 2023 | 594.88K | 156.61K | 35.73% |
| Dec 31, 2022 | 438.27K | 340.54K | 348.43% |
| Dec 31, 2021 | 97.74K | 45.84K | 88.32% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Sofgen Pharma | 373.80M |
| Tian'an Pharmaceutical | 10.65M |
| Target Group | 3.50M |
| Cannabis Global | 1.06M |
| LiveWire Ergogenics | 571.68K |
| Herborium Group | 259.10K |
| Sky Century Investment | 126.22K |
| CBD Life Sciences | 98.32K |